GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kohjin Bio Co Ltd (TSE:177A) » Definitions » Beneish M-Score

Kohjin Bio Co (TSE:177A) Beneish M-Score : -2.50 (As of Mar. 28, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Kohjin Bio Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.50 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Kohjin Bio Co's Beneish M-Score or its related term are showing as below:

TSE:177A' s Beneish M-Score Range Over the Past 10 Years
Min: -2.5   Med: -2.5   Max: -2.5
Current: -2.5

During the past 3 years, the highest Beneish M-Score of Kohjin Bio Co was -2.50. The lowest was -2.50. And the median was -2.50.


Kohjin Bio Co Beneish M-Score Historical Data

The historical data trend for Kohjin Bio Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kohjin Bio Co Beneish M-Score Chart

Kohjin Bio Co Annual Data
Trend Mar22 Mar23 Mar24
Beneish M-Score
- - -2.50

Kohjin Bio Co Quarterly Data
Mar22 Mar23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial - - -2.50 - -

Competitive Comparison of Kohjin Bio Co's Beneish M-Score

For the Biotechnology subindustry, Kohjin Bio Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kohjin Bio Co's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Kohjin Bio Co's Beneish M-Score falls into.


;
;

Kohjin Bio Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Kohjin Bio Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1004+0.528 * 1.312+0.404 * 1.1395+0.892 * 1.0057+0.115 * 0.6902
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.066578-0.327 * 0.9705
=-2.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was 円747 Mil.
Revenue was 円4,770 Mil.
Gross Profit was 円1,881 Mil.
Total Current Assets was 円3,410 Mil.
Total Assets was 円6,589 Mil.
Property, Plant and Equipment(Net PPE) was 円2,587 Mil.
Depreciation, Depletion and Amortization(DDA) was 円300 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円2,398 Mil.
Long-Term Debt & Capital Lease Obligation was 円767 Mil.
Net Income was 円385 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円824 Mil.
Total Receivables was 円675 Mil.
Revenue was 円4,743 Mil.
Gross Profit was 円2,454 Mil.
Total Current Assets was 円3,479 Mil.
Total Assets was 円6,135 Mil.
Property, Plant and Equipment(Net PPE) was 円2,172 Mil.
Depreciation, Depletion and Amortization(DDA) was 円168 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円3,022 Mil.
Long-Term Debt & Capital Lease Obligation was 円15 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(747.435 / 4770.096) / (675.398 / 4742.992)
=0.156692 / 0.142399
=1.1004

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2454.182 / 4742.992) / (1881.296 / 4770.096)
=0.517433 / 0.394394
=1.312

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3409.829 + 2586.755) / 6589.322) / (1 - (3478.946 + 2171.577) / 6134.824)
=0.089954 / 0.078943
=1.1395

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4770.096 / 4742.992
=1.0057

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(167.589 / (167.589 + 2171.577)) / (299.629 / (299.629 + 2586.755))
=0.071645 / 0.103808
=0.6902

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 4770.096) / (0 / 4742.992)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((767.034 + 2398.213) / 6589.322) / ((14.921 + 3021.627) / 6134.824)
=0.48036 / 0.494969
=0.9705

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(384.978 - 0 - 823.681) / 6589.322
=-0.066578

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Kohjin Bio Co has a M-score of -2.50 suggests that the company is unlikely to be a manipulator.


Kohjin Bio Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Kohjin Bio Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Kohjin Bio Co Business Description

Traded in Other Exchanges
N/A
Address
5-1-3 Chiyoda, Sakado, Saitama, JPN, 350-0214
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.

Kohjin Bio Co Headlines

No Headlines